Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOCOPROM: Tocolysis in PPROM Before 34 Weeks
NCT03976063Phase 3Active, not recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2019
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nifedipine GITS in preterm premature rupture of membranes (pPROM), sponsored by Assistance publique - Hôpitaux de Paris. Started Oct 2019; status: active, not recruiting.
02
Drugs
nifedipine GITS
03
Conditions
preterm premature rupture of membranes (pPROM)
Beyond the preview
Go deeper on NCT03976063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03976063.